Cargando…
Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
The epithelial mesenchymal transition (EMT) is the process by which cancer cells of epithelial origin, including endometrial cancer, acquire a mesenchymal phenotype with enhanced migratory and invasive capacity, to facilitate metastasis. The regulation of EMT is tissue-specific, and in endometrial c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424890/ https://www.ncbi.nlm.nih.gov/pubmed/36052252 http://dx.doi.org/10.3389/fonc.2022.914405 |
_version_ | 1784778325065990144 |
---|---|
author | Gelissen, Julia H. Huang, Gloria S. |
author_facet | Gelissen, Julia H. Huang, Gloria S. |
author_sort | Gelissen, Julia H. |
collection | PubMed |
description | The epithelial mesenchymal transition (EMT) is the process by which cancer cells of epithelial origin, including endometrial cancer, acquire a mesenchymal phenotype with enhanced migratory and invasive capacity, to facilitate metastasis. The regulation of EMT is tissue-specific, and in endometrial cancer, endocrine signaling pathways serve as critical regulators of EMT. The intersections of endocrine signaling and EMT highlight potential avenues for therapeutic intervention to target cancer metastasis with the aim of reduced mortality. |
format | Online Article Text |
id | pubmed-9424890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94248902022-08-31 Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer Gelissen, Julia H. Huang, Gloria S. Front Oncol Oncology The epithelial mesenchymal transition (EMT) is the process by which cancer cells of epithelial origin, including endometrial cancer, acquire a mesenchymal phenotype with enhanced migratory and invasive capacity, to facilitate metastasis. The regulation of EMT is tissue-specific, and in endometrial cancer, endocrine signaling pathways serve as critical regulators of EMT. The intersections of endocrine signaling and EMT highlight potential avenues for therapeutic intervention to target cancer metastasis with the aim of reduced mortality. Frontiers Media S.A. 2022-08-16 /pmc/articles/PMC9424890/ /pubmed/36052252 http://dx.doi.org/10.3389/fonc.2022.914405 Text en Copyright © 2022 Gelissen and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Gelissen, Julia H. Huang, Gloria S. Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title | Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title_full | Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title_fullStr | Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title_full_unstemmed | Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title_short | Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
title_sort | intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424890/ https://www.ncbi.nlm.nih.gov/pubmed/36052252 http://dx.doi.org/10.3389/fonc.2022.914405 |
work_keys_str_mv | AT gelissenjuliah intersectionsofendocrinepathwaysandtheepithelialmesenchymaltransitioninendometrialcancer AT huangglorias intersectionsofendocrinepathwaysandtheepithelialmesenchymaltransitioninendometrialcancer |